Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma

Antitumor Effect ◽

Human Malignant Melanoma ◽

Abstract 4078: Antitumor effect of the histone deacetylase inhibitor MS-275 in combination with retinoic acid Am80 in human cutaneous T-cell lymphoma

10.1158/1538-7445.am2012-4078 ◽

2012 ◽

Author(s):

Yukihiko Kato ◽

Chizu Egusa ◽

Tatsuo Maeda ◽

Ryoji Tsuboi

Keyword(s):

Retinoic Acid ◽

T Cell ◽

Histone Deacetylase ◽

Antitumor Effect ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Cutaneous T Cell Lymphoma ◽

Synergistic In vivo Antitumor Effect of the Histone Deacetylase Inhibitor MS-275 in Combination with Interleukin 2 in a Murine Model of Renal Cell Carcinoma

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-07-0014 ◽

2007 ◽

Vol 13 (15) ◽

pp. 4538-4546 ◽

Cited By ~ 59

Author(s):

Yukihiko Kato ◽

Kiyoshi Yoshimura ◽

Tahiro Shin ◽

Henk Verheul ◽

Hans Hammers ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Histone Deacetylase ◽

Murine Model ◽

Renal Cell ◽

Antitumor Effect ◽

Interleukin 2 ◽

Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours

British Journal of Cancer ◽

10.1038/bjc.2011.527 ◽

2011 ◽

Vol 106 (1) ◽

pp. 77-84 ◽

Cited By ~ 101

Author(s):

R Pili ◽

B Salumbides ◽

M Zhao ◽

S Altiok ◽

D Qian ◽

...

Keyword(s):

Retinoic Acid ◽

Phase I ◽

Histone Deacetylase ◽

Phase I Study ◽

Solid Tumours ◽

Retinoic Acid and Histone Deacetylase Inhibitor BML-210 Inhibit Proliferation of Human Cervical Cancer HeLa Cells

Annals of the New York Academy of Sciences ◽

10.1196/annals.1378.079 ◽

2006 ◽

Vol 1091 (1) ◽

pp. 346-355 ◽

Cited By ~ 14

Author(s):

VERONIKA V. BORUTINSKAITE ◽

RUTA NAVAKAUSKIENE ◽

KARL-ERIC MAGNUSSON

Keyword(s):

Cervical Cancer ◽

Retinoic Acid ◽

Histone Deacetylase ◽

Hela Cells ◽

Deacetylase Inhibitor ◽

Human Cervical Cancer

The Histone Deacetylase Inhibitor FK228 Distinctly Sensitizes the Human Leukemia Cells to Retinoic Acid-Induced Differentiation

Annals of the New York Academy of Sciences ◽

10.1196/annals.1378.081 ◽

2006 ◽

Vol 1091 (1) ◽

pp. 368-384 ◽

Cited By ~ 16

Author(s):

JURATE SAVICKIENE ◽

GRAZINA TREIGYTE ◽

VERONIKA BORUTINSKAITE ◽

RUTA NAVAKAUSKIENE ◽

KARL-ERIC MAGNUSSON

Keyword(s):

Retinoic Acid ◽

Histone Deacetylase ◽

Leukemia Cells ◽

Human Leukemia ◽

Induced Differentiation ◽

Human Leukemia Cells ◽

New Promising Therapeutic Modalities for Thyroid Cancers: Histone Deacetylase Inhibitor, PPAR-gamma Agonist, and Retinoic Acid

The Korean Journal of Endocrine Surgery ◽

10.16956/kjes.2005.5.2.69 ◽

2005 ◽

Vol 5 (2) ◽

pp. 69

Author(s):

Woung Youn Chung ◽

Orlo H Clark

Keyword(s):

Retinoic Acid ◽

Histone Deacetylase ◽

Ppar Gamma ◽

Thyroid Cancers ◽

Therapeutic Modalities ◽

Deacetylase Inhibitor ◽

Ppar Gamma Agonist

Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells

Cancer Chemotherapy and Pharmacology ◽

10.1007/s002800100294 ◽

2001 ◽

Vol 48 (1) ◽

pp. 71-76 ◽

Cited By ~ 93

Author(s):

Veronica Bovenzi ◽

Richard Momparler

Keyword(s):

Estrogen Receptor ◽

Retinoic Acid ◽

Breast Carcinoma ◽

Histone Deacetylase ◽

Retinoic Acid Receptor ◽

Estrogen Receptor Α ◽

Carcinoma Cells ◽

Breast Carcinoma Cells ◽

Histone deacetylase inhibitor FK228 suppresses the Ras–MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma

Oncogene ◽

10.1038/sj.onc.1209072 ◽

2005 ◽

Vol 25 (4) ◽

pp. 512-524 ◽

Cited By ~ 37

Author(s):

Y Kobayashi ◽

M Ohtsuki ◽

T Murakami ◽

T Kobayashi ◽

K Sutheesophon ◽

...

Keyword(s):

Malignant Melanoma ◽

Map Kinase ◽

Signaling Pathway ◽

Histone Deacetylase ◽

Kinase Signaling ◽

Deacetylase Inhibitor ◽

Map Kinase Signaling ◽

Kinase Signaling Pathway ◽

Map Kinase Signaling Pathway

Acetylation of α-tubulin by a Histone Deacetylase Inhibitor, Resminostat, Leads Synergistic Antitumor Effect with Docetaxel in Non-Small Cell Lung Cancer Models

International Journal of Cancer and Clinical Research ◽

10.23937/2378-3419/1410077 ◽

2017 ◽

Vol 4 (1) ◽

Cited By ~ 1

Author(s):

Hiroaki Konishi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Histone Deacetylase ◽

Cell Lung Cancer ◽

Antitumor Effect ◽

Small Cell ◽

Small Cell Lung ◽

Cancer Models ◽

Molecular profiling of embryonal carcinoma cells following retinoic acid or histone deacetylase inhibitor treatment

Cancer Biology & Therapy ◽

10.4161/cbt.3.11.1190 ◽

2004 ◽

Vol 3 (11) ◽

pp. 1109-1120 ◽

Cited By ~ 29

Author(s):

Niquiche Sangster-Guity ◽

Li-Ming Yu ◽

Paulette McCormick

Keyword(s):

Retinoic Acid ◽

Histone Deacetylase ◽

Embryonal Carcinoma ◽

Molecular Profiling ◽

Carcinoma Cells ◽

Embryonal Carcinoma Cells ◽

Deacetylase Inhibitor ◽

Inhibitor Treatment